Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia
- 1 November 2004
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 177 (1) , 137-145
- https://doi.org/10.1016/j.atherosclerosis.2004.06.011
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- HDL and triglyceride as therapeutic targetsCurrent Opinion in Lipidology, 2002
- Role of ApoCs in Lipoprotein MetabolismArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Polymorphic Markers in Apolipoprotein C-III Gene Flanking Regions and HypertriglyceridemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and EArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Plasma triglyceride and coronary heart disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administrationAtherosclerosis, 1989
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoproteinBiochemical and Biophysical Research Communications, 1972